What Can Your Genomic Technology Do If a SARS- or Avian Flu-like Illness Emerged Today?

Read Transcript

We have been fortunate enough to be able to apply our  technology to critically all patients right here in our clinics  at UCS and Serfans. So we'll just take a real example. A patient comes in, a young woman who has no travel history, no other risk factor and has trouble breathing and has a fever.

She rapidly progresses to respiratory distress, meaning, she can not breathe on her own, and mechanically ventilator meaning they make a machine breathe for her. She has total lung failure. She has all the hallmarks  of infectious disease, a fever, but examination can't see any bacteria, can't see any fungus, I send out all the the major diagnostics, for influenza for lungs and turns out nothing SARS, hanta virus, even exotic agency, when normal expectance region.

Everything come out negative, day after day after day. Biotechnology it can actually sequence those samples and understand what the infectious engineers incase of misparticular case we are frefering to, we are actually predisesor of the technology of the Microsoft and then sequence state and that was able to find a virus that nobody thought would actually be there and one was the radars, but they can't crosses respitory the stress and that I think it is acrucial piece of information because there are a lot of therapies so in a lot od operations example no open mind biopsy, but you just wouldn't do if you knew that virus was there.

But technology that we have today is supposed to just five years ago we are doing cases like that, could do this faster, better, cheaper and more specific than ever, and so I think we are on the cast of a whole new generation of diagnostics, not just for infectious disease, but for our immunity, cancer, for any kind of human condition, and that applies to all the creatures around us as well that ordinary medicine insects we rely on for agriculture you name it.